The random nature of transrectal ultrasound (TRUS) guided systematic prostate biopsy sampling and low specificity of prostate specific antigen (PSA) have induced overtreatment of clinically indolent prostate cancer (PCa) and missed diagnosis of significant ones [1]. The gene discussed is KLK3; the disease is prostate cancer.